Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Avalon Globocare (AVCO)

Avalon Globocare (AVCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
EchoStar Arm Hikes on $50M Grant Baystreet - Wed Jan 10, 8:58AM CST

DISH Wireless, a subsidiary of EchoStar (NASDAQ:SATS), was awarded a historic $50-million grant from ...

AVCO : 0.5259 (-16.52%)
ADI : 209.65 (+1.60%)
ARM : 128.66 (-0.05%)
CSCO : 57.31 (-0.26%)
DELL : 136.01 (+3.32%)
INTC : 24.84 (+2.01%)
QCOM : 164.50 (+2.49%)
SATS : 23.68 (+3.91%)
Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society Globe Newswire - Mon Aug 8, 2022

Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications Reports...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer Globe Newswire - Thu Jun 30, 2022

FREEHOLD, N.J., June 30, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference Globe Newswire - Wed May 25, 2022

FREEHOLD, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies Globe Newswire - Mon Feb 14, 2022

Leveraging Avalon’s existing Flash-CARTM technology platform to develop next-generation mRNA-based CAR-NK cellular therapeuticsClinical development of...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs Globe Newswire - Tue Jan 4, 2022

Company continues to expand and accelerate its R&D strategies for high-impact translational and clinical programs in the US and Europe Intended...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to Market Globe Newswire - Wed Dec 22, 2021

Avalon’s Chairman converts $3.0 million of debt into common stock at $1.25 per share showing continued confidence and support of the business...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development Globe Newswire - Thu Dec 9, 2021

Avalon and research partner, Massachusetts Institute of Technology (MIT), combine their protein design “QTY Code” technology with Google’s DeepMind...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy Globe Newswire - Thu Oct 14, 2021

Co-developed novel technology platform combining S-layer proteins and emulsomes for diverse applications in bio-delivery of drugs and genes with the...

AVCO : 0.5259 (-16.52%)
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases Globe Newswire - Thu Oct 7, 2021

Avalon and research partner, University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria, co-develop a novel technology to efficiently...

AVCO : 0.5259 (-16.52%)

Barchart Exclusives

Stock Index Futures Slip on Worries Over Russia-Ukraine Escalation, U.S. Housing Data and Walmart Earnings on Tap Barchart - 33 minutes ago
December S&P 500 E-Mini futures (ESZ24) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.32% this morning as risk sentiment took a hit after Russian President Vladimir Putin updated the country’s nuclear doctrine, while investors awaited fresh data on the U.S. housing market and an earnings report from retail giant Walmart. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot